Emphysema did not significantly affect the response to systemic therapy in patients with severe asthma, according to a recent retrospective study. Early improvement was linked to lower baseline FEV1 ...
Severe asthma does not respond well to regular asthma treatments, such as inhaled corticosteroids and inhaled bronchodilator medications. Those with severe asthma usually find their symptoms ...
Earlier this year, researchers of Brigham and Women’s Hospital Harvard Medical School looked at clinical trials to show how six biologics, in particular, improve lung function; cut down on steroid use ...
Bafadhel said the breakthrough study has demonstrated that Benralizumab, a drug already in use for managing severe asthma, may offer superior treatment for exacerbations of asthma and COPD ...
It is currently used for the treatment of severe asthma. The ABRA trial has found a single dose can be more effective when injected at the point of exacerbation compared to steroid tablets.